医療向け人間拡張の世界市場：バイオニクス、臓器・身体部位置換、外骨格、ロボティクス（2023年～2028年）

当レポートでは、世界の医療向け人間拡張市場について調査し、技術の評価、製品とサービスのレビュー、用途の評価、業界に対する影響の評価、競合の分析などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 イントロダクション

• バイオニクスの概要
• バイオニクスの製品と応用産業
• バイオニクスの促進要因
  • 医療技術の進歩
  • 人口の高齢化による臓器不全の増加
  • 切断事故
  • 外骨格の用途
  • ロボティクスの代替
  • 政府の研究開発イニシアチブ
  • 特に新興国における所得の増加
• バイオニクス市場の抑制要因
  • 装置と治療の高いコスト
  • 政府の規制と厳格な承認プロセス
  • 外科の専門知識の欠如
• 社会に対するバイオニクスの影響
  • プラスの影響
  • マイナスの影響

第3章 バイオニクス技術と市場の発展

• メディカルバイオニクス製品
• 装具・補綴物
• 人工臓器
• 強化外骨格
  • 医療用外骨格
  • 軍事用外骨格
  • 補助外骨格
• ヒューマンバイオニクス
• メカニカル vs. エレクトロニクスバイオニクス
• 人工インプラント vs. ウェアラブルバイオニクス
• 3Dプリンティングとバイオニクス
• バイオニクスとAI
• ナノテクノロジーとバイオニクス
• ビジネスバイオミメティック
• サイバネティックオーガニズム
• バイオニクス業界の情勢

第4章 使用事例

• HELLEN - 外骨格
• てんかん発作の追跡と予測
• フィットネス向け外骨格の設計
• ロボット外骨格のケーススタディ
• リウォーク外骨格
• 磁気エンコーダーにより「人生を変える」外骨格の構築が可能に
• インディゴ外骨格

第5章 人間拡張市場の分析と収益予測

• バイオニクスの総収益（2023年～2028年）
• バイオニクスの収益：業界別（2023年～2028年）
• メディカルバイオニクスの収益（2023年～2028年）
  • メディカルバイオニクスの収益：製品カテゴリ別
  • メディカルバイオニクスの収益：用途タイプ別
  • 植込み型メディカルバイオニクスの収益：製品タイプ別
  • メディカルバイオニクスの収益：技術タイプ別
  • メディカルメカニカルバイオニクスの収益：製品タイプ別
  • メディカルバイオニクスの収益：エンドユーザータイプ別
  • メディカルバイオニクスの収益：地域別
  • 北米のメディカルバイオニクスの収益：国別
  • 欧州のメディカルバイオニクスの収益：国別
  • アジア太平洋のメディカルバイオニクスの収益：国別
  • ラテンアメリカ・中東・アフリカのメディカルバイオニクスの収益：国別
• 防衛向け外骨格バイオニクスの収益（2023年～2028年）
  • 防衛向け外骨格バイオニクスの収益：製品カテゴリ別
  • 防衛向け外骨格バイオニクスの収益：技術タイプ別
  • 防衛向け外骨格バイオニクスの収益：地域別
  • 北米の防衛向け外骨格バイオニクスの収益：国別
  • アジア太平洋の防衛向け外骨格バイオニクスの収益：国別
  • 欧州の防衛向け外骨格バイオニクスの収益：国別
  • その他の地域の防衛向け外骨格バイオニクスの収益：国別

第6章 企業と分析

• 戦略的取り組み
• Abbott Laboratories
• AbbVie Inc.
• Abiomed
• Asahi Kasei Kuraray Medical Co. Ltd.
• Baxter International
• Zimmer Biomet Holdings
• Boston Scientific Corporation
• Cochlear Ltd.
• Edwards Lifesciences Corporation
• Ekso Bionics Holdings Inc.
• LivaNova PLC
• Medtronic plc
• Orthofix Holdings Inc.
• Otto Bock HealthCare GmBH
• Sonova Holding AG
• Ossur Corporate
• SynCardia Systems LLC
• Bionic Power
• ExoAtlet
• Lockheed Martin Corporation
• RB3D
• Sarcos Corporation
• Spring Active
• SRI International

第7章 結論と市場見通し

Figures

• Figure 1: Bionics Product and Application Ecosystem
• Figure 2: Bionics Industry Landscape
• Figure 3: Global Bionics Market Revenue 2023 - 2028

Tables

• Table 1: Global Bionics Revenue by Industry Vertical 2023 - 2028
• Table 2: Global Medical Bionics Revenue by Product Category 2023 - 2028
• Table 3: Global Orthopaedic Bionics Revenue by Product Type 2023 - 2028
• Table 4: Global Bionics Limbs Revenue by Product Type 2023 - 2028
• Table 5: Global Bionics Lower Limbs Revenue by Product Type 2023 - 2028
• Table 6: Global Electrical Bone Growth Stimulators Revenue by Product Type 2023 - 2028
• Table 7: Global Cardiac Bionics Revenue by Product Type 2023 - 2028
• Table 8: Global Artificial Organs Revenue by Product Type 2023 - 2028
• Table 9: Global Artificial Heart Valves Revenue by Product Type 2023 - 2028
• Table 10: Global Bionics Pacemaker Revenue by Product Type 2023 - 2028
• Table 11: Global Bionics Ventricular Assist Device (VADs) Revenue by Product Type 2023 - 2028
• Table 12: Global Neural/Brain Bionics Revenue by Product Type 2023 - 2028
• Table 13: Global Bionics Internal Neurostimulators Revenue by Product Type 2023 - 2028
• Table 14: Global Bionics Ear Revenue by Product Type 2023 - 2028
• Table 15: Global Medical Bionics Revenue by Application Type 2023 - 2028
• Table 16: Global Implantable Medical Bionics Revenue by Product Type 2023 - 2028
• Table 17: Global Externally Worn Medical Bionics Revenue by Product Type 2023 - 2028
• Table 18: Global Medical Bionics Revenue by Technology Type 2023 - 2028
• Table 19: Global Medical Mechanical Bionics Revenue by Product Type 2023 - 2028
• Table 20: Global Medical Electronic Bionics Revenue by Product Type 2023 - 2028
• Table 21: Global Medical Bionics Revenue by End User Type 2023 - 2028
• Table 22: Medical Bionics Revenue by Region 2023 - 2028
• Table 23: North America Medical Bionics Revenue by Country 2023 - 2028
• Table 24: Europe Medical Bionics Revenue by Country 2023 - 2028
• Table 25: APAC Medical Bionics Revenue by Country 2023 - 2028
• Table 26: SEA Medical Bionics Revenue by Country 2023 - 2028
• Table 27: LAMEA Medical Bionics Revenue by Country 2023 - 2028
• Table 28: Global Defense Exoskeleton Bionics Revenue by Product Category 2023 - 2028
• Table 29: Global Defense Exoskeleton Revenue by Technology Type 2023 - 2028
• Table 30: Defense Exoskeleton Bionics Revenue by Region 2023 - 2028
• Table 31: North America Defense Exoskeleton Bionics Revenue by Country 2023 - 2028
• Table 32: APAC Defense Exoskeleton Bionics Revenue by Country 2023 - 2028
• Table 33: Europe Defense Exoskeleton Bionics Revenue by Country 2023 - 2028
• Table 34: ROW Defense Exoskeleton Bionics Revenue by Country 2023 - 2028

Human Augmentation represents mechanical and electronic additions to the human body to improve various body functions. In the healthcare sector, augmentation may include bionics, organ replacement, exoskeletons, and robotics to provide assistance to those that have physical impairments. The goals of augmentation are many and varied such as rehabilitation, elder care, work and lifestyle enablement.

In many cases, the goal is to replicate biological methods and systems found in nature via electrically or mechanically powered artificial devices. Examples range from artificial organ or body part replacement to exoskeleton suit or robotics. In the case of collaborative robots (Co-Bots), robotics is used in collaboration with a human being to enable functions that would otherwise be prohibitive due to physical limitations.

Bionics represents the application of biological methods and systems found in nature, leverage to support the healthcare industry via electrically and/or mechanically powered artificial devices. Devices include artificial organs, body parts, and exoskeleton, which either replaces damaged or weakened body parts. These devices act as the original functions very closely. The exoskeleton suit has also been used in other purposes like rehabilitation and elder care.

This human augmentation report addresses the market for bionics, organ replacement, exoskeletons, and robotics in the healthcare sector including technology assessment, product and service review, application evaluation, industry impact assessment, and competitive analysis. The report includes detailed forecasts covering many aspects of human augmentation in healthcare for 2023 through 2028.

Companies in Report:

Table of Contents

1.0. Executive Summary

2.0. Introduction

• 1.1. Bionics Overview
• 1.2. Bionics Products and Application Industry
• 1.3. Bionics Growth Drivers
  • 1.3.1. Healthcare Technology Advancement
  • 1.3.2. Aging Population to Increase Organ Failure
  • 1.3.3. Accident to Amputations
  • 1.3.4. Exoskeleton Application
  • 1.3.5. Substitute of Robotics
  • 1.3.6. Government R&D Initiative
  • 1.3.7. Increase of Income Especially in Emerging Economies
• 1.4. Bionics Market Limitations
  • 1.4.1. High Cost of Device and Treatment
  • 1.4.2. Government Regulations and Strict Approval process
  • 1.4.3. Lack of Surgical Expertise
• 1.5. Bionics Impact on Society
  • 1.5.1. Positive Impact
  • 1.5.2. Negative Impact

2. Bionics Technology and Market Development

• 2.1. Medical Bionics Products
• 2.2. Orthotics and Prosthetics
• 2.3. Artificial Organ
• 2.4. Powered Exoskeleton
  • 2.4.1. Medical Exoskeleton
  • 2.4.2. Military Exoskeleton
  • 2.4.3. Assistive Exoskeleton
• 2.5. Human Bionics
• 2.6. Mechanical vs. Electronics Bionics
• 2.7. Artificial Implants vs. Wearable Bionics
• 2.8. 3D Printing and Bionics
• 2.9. Bionics and Artificial Intelligence
• 2.10. Nanotechnology and Bionics
• 2.11. Business Biomimetic
• 2.12. Cybernetic Organism
• 2.13. Bionics Industry Landscape

3. Use Cases and Examples

• 3.1. HELLEN-The Exoskeleton
• 3.2. Tracking and Predicting Epilepsy Seizures
• 3.3. Designing an Exoskeleton for Fitness
• 3.4. Robotic Exoskeleton Case Study
• 3.5. ReWalk Exoskeleton
• 3.6. Magnetic Encoders Allows the Building of 'Life-Changing' Exoskeletons
• 3.7. Indego Exoskeleton

4. Human Augmentation Market Analysis and Revenue Forecasts

• 4.1. Combined Bionics Revenue 2023-2028
• 4.2. Bionics Revenue by Industry Vertical 2023-2028
• 4.3. Medical Bionics Revenue 2023-2028
  • 4.3.1. Medical Bionics Revenue by Product Category
  • 4.3.2. Medical Bionics Revenue by Application Type
  • 4.3.3. Implantable Medical Bionics Revenue by Product Type
  • 4.3.4. Medical Bionics Revenue by Technology Type
  • 4.3.5. Medical Mechanical Bionics Revenue by Product Type
  • 4.3.6. Medical Bionics Revenue by End User Type
  • 4.3.7. Medical Bionics Revenue by Region
  • 4.3.8. North America Medical Bionics Revenue by Country
  • 4.3.9. Europe Medical Bionics Revenue by Country
  • 4.3.10. APAC Medical Bionics Revenue by Country
  • 4.3.11. LAMEA Medical Bionics Revenue by Country
• 4.4. Defense Exoskeleton Bionics Revenue 2023-2028
  • 4.4.1. Defense Exoskeleton Bionics Revenue by Product Category
  • 4.4.2. Defense Exoskeleton Bionics Revenue by Technology Type
  • 4.4.3. Defense Exoskeleton Bionics Revenue by Region
  • 4.4.4. North America Defense Exoskeleton Bionics Revenue by Country
  • 4.4.5. APAC Defense Exoskeleton Bionics Revenue by Country
  • 4.4.6. Europe Defense Exoskeleton Bionics Revenue by Country
  • 4.4.7. ROW Defense Exoskeleton Bionics Revenue by Country

5. Company and Analysis

• 5.1. Strategic Initiatives
• 5.2. Abbott Laboratories
• 5.3. AbbVie Inc.
• 5.4. Abiomed
• 5.5. Asahi Kasei Kuraray Medical Co. Ltd.
• 5.6. Baxter International
• 5.7. Zimmer Biomet Holdings
• 5.8. Boston Scientific Corporation
• 5.9. Cochlear Ltd.
• 5.10. Edwards Lifesciences Corporation
• 5.11. Ekso Bionics Holdings Inc.
• 5.12. LivaNova PLC
• 5.13. Medtronic plc
• 5.14. Orthofix Holdings Inc.
• 5.15. Otto Bock HealthCare GmBH
• 5.16. Sonova Holding AG
• 5.17. Ossur Corporate
• 5.18. SynCardia Systems LLC
• 5.19. Bionic Power
• 5.20. ExoAtlet
• 5.21. Lockheed Martin Corporation
• 5.22. RB3D
• 5.23. Sarcos Corporation
• 5.24. Spring Active
• 5.25. SRI International

6. Conclusions and Market Outlook